3 / 3
Global Cardiology Congress 2019
Journal of Cardiovascular Medicine and Therapeutics | Volume 3
Page 16
June 19-20, 2019 | Dublin, Ireland
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
CARDIOLOGY AND
CARDIOVASCULAR MEDICINE
6
th
International Conference on
Complete counseling was given prior to admission and the patient accepted erythropoietin and synthesized the coag-
ulation factors. Finally, informed consent was registered. Surgery allowed intravenous iron supplementation and sub-
cutaneous erythropoietin for two weeks before the operation. The dietician and physiotherapist’s assessment was also
scheduled.
Results:
The patient went on to successfully recovery postoperatively. Highlight points: The importance of develop-
ing ERAS program through a fully structured and well organized sequence of perioperative care, in order to improve
not only efficiency by shortening the hospital stay but also decreasing the surgical stress response; The importance
of transfusion avoidance strategies, the availability of bloodless cardiovascular surgical procedures and perioperative
multimodal treatments as a chance for reviewing the conventional protocols such as transfusional policy.
Conclusion:
The implementation of ERAS program in cardiac surgery, even in high-risk patients such as JWs, represents
a significant change in traditional clinical practice and a potential increase in the use of resources.